a randomized, double-blind, placebo controlled-trial of  xxxd3435xxx  in mild cognitive impairment: the trimci study.  amnestic mild cognitive impairment represents, in many cases, the earliest clinical phases of  xxxg178xxx . anti-inflammatory agents have epidemiologic support as drugs potentially beneficial in  xxxg178xxx . in vivo studies have shown that  xxxd3435xxx  and its active metabolite 2-hydroxy-4-trifluoromethyl- xxxd306xxx  have potent anti-inflammatory actions in the central nervous system.